605681-01-4 Usage
General Description
Pyridine, 2-(bromomethyl)-5-chloro- (9CI) is a chemical compound with the molecular formula C7H6BrClN. It is a derivative of pyridine, a six-membered heterocyclic compound containing a ring of five carbon atoms and one nitrogen atom. The compound contains a bromomethyl and chlorine group attached to the pyridine ring, making it a halogenated organic compound. It is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. The compound's properties and reactivity make it suitable for a wide range of applications in organic synthesis. However, it is important to handle and use this compound with caution due to its potential health hazards and environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 605681-01-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,5,6,8 and 1 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 605681-01:
(8*6)+(7*0)+(6*5)+(5*6)+(4*8)+(3*1)+(2*0)+(1*1)=144
144 % 10 = 4
So 605681-01-4 is a valid CAS Registry Number.
605681-01-4Relevant articles and documents
NOVEL TETRAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF TUBERCULOSIS
-
Page/Page column 36, (2019/03/05)
The invention relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by mycobacterium, such as tuberculosis.
1-(DIHYDRONAPHTHALENYL)PYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS
-
Page/Page column 51, (2013/12/03)
This invention relates to novel 1-(dihydronaphthalenyl)pyridones which are antagonists of the melanin-concentrating hormone receptor 1 (MCHR1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy
4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS
-
Page/Page column 107, (2011/10/10)
The present invention relates to novel compounds for use in the compositions, to processes for their preparation, to intermediates useful in their preparation and to their use as therapeutic agents. The present invention also relates to pharmaceutical com